| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6e7b22003da49eaf7bb16f3a8e9b331 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0385b57c936edc62210f4b513c20cb1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb0186a70e47fc0cd682c3d11555cb33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b15005c3d2cb0995d2732e5cc68f0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b74150fa8f2a69125297c02cdf0fd134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa8481f30ed8389830c84a216da0a30e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a78426e9f9d1fa23fa15a682574f3bd0 |
| publicationDate |
2016-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016058751-A1 |
| titleOfInvention |
Composition and method for treating cancer |
| abstract |
The present disclosure relates to a pharmaceutical composition and a kit to treat cancer. The disclosure provides a combination of compounds for use in the treatment of cancer. The disclosure further provides a process of preparing the composition and a method of treating a cancer associated with a RAS mutation or a RAS mutation along with any other mutation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11760714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112263568-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11613511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407705-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109293537-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020243063-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021137934-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020223583-A1 |
| priorityDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |